APO Research
Talk to an analyst

APO RESEARCH · REPORT

Romosozumab

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Romosozumab Industry Growth and Trends Forecast to 2032

23 December 202575 pages

Choose your research edition.

Industry ResearchRomosozumab Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Romosozumab Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Romosozumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Romosozumab Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Romosozumab Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Romosozumab market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Romosozumab is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Romosozumab is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Romosozumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Romosozumab include Thermo Fisher Scientific, Bristol-Myers Squibb and Celgene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Romosozumab market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Romosozumab market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Romosozumab market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Romosozumab.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Romosozumab market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Romosozumab Market by Company

Thermo Fisher Scientific

Bristol-Myers Squibb

Celgene

Romosozumab Segment by Type

25 mg/vial

75 mg/vial

Romosozumab Segment by Application

Beta-thalassemia

MDS-RS

Romosozumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Romosozumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Romosozumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Romosozumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Romosozumab manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Romosozumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 25 mg/vial Table 2. Major Company of 75 mg/vial Table 3. Global Romosozumab Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Romosozumab Sales by Type (2021-2026) & (k units) Table 5. Global Romosozumab Sales Market Share in Volume by Type (2021-2026) Table 6. Global Romosozumab Sales by Type (2021-2026) & (US$ Million) Table 7. Global Romosozumab Sales Market Share in Value by Type (2021-2026) Table 8. Global Romosozumab Price by Type (2021-2026) & (USD/unit) Table 9. Global Romosozumab Sales by Type (2027-2032) & (k units) Table 10. Global Romosozumab Sales Market Share in Volume by Type (2027-2032) Table 11. Global Romosozumab Sales by Type (2027-2032) & (US$ Million) Table 12. Global Romosozumab Sales Market Share in Value by Type (2027-2032) Table 13. Global Romosozumab Price by Type (2027-2032) & (USD/unit) Table 14. North America Romosozumab Sales by Type (2021-2026) & (k units) Table 15. North America Romosozumab Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Romosozumab Sales by Type (2021-2026) & (k units) Table 17. Europe Romosozumab Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Romosozumab Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Romosozumab Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Romosozumab Sales by Type (2021-2026) & (k units) Table 21. Latin America Romosozumab Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Romosozumab Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Romosozumab Sales by Type (2021-2026) & (US$ Million) Table 24. Romosozumab Industry Trends Table 25. Romosozumab Industry Drivers Table 26. Romosozumab Industry Opportunities and Challenges Table 27. Romosozumab Industry Restraints Table 28. Global Romosozumab Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Romosozumab Revenue Market Share by Company (2021-2026) Table 30. Global Romosozumab Sales by Company (2021-2026) & (k units) Table 31. Global Romosozumab Sales Share by Company (2021-2026) Table 32. Global Romosozumab Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Romosozumab Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Romosozumab Major Company Production Sites and Headquarters Table 35. Global Romosozumab Company, Product Type & Application Table 36. Global Romosozumab Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Romosozumab by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Romosozumab Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Romosozumab Sales by Region (2021-2026) & (k units) Table 41. Global Romosozumab Sales Market Share in Volume by Region (2021-2026) Table 42. Global Romosozumab Sales by Region (2021-2026) & (US$ Million) Table 43. Global Romosozumab Sales Market Share in Value by Region (2021-2026) Table 44. Global Romosozumab Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Romosozumab Sales by Region (2027-2032) & (k units) Table 46. Global Romosozumab Sales Market Share in Volume by Region (2027-2032) Table 47. Global Romosozumab Sales by Region (2027-2032) & (US$ Million) Table 48. Global Romosozumab Sales Market Share in Value by Region (2027-2032) Table 49. Global Romosozumab Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Romosozumab Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Romosozumab Sales by Application (2021-2026) & (k units) Table 52. Global Romosozumab Sales Market Share in Volume by Application (2021-2026) Table 53. Global Romosozumab Sales by Application (2021-2026) & (US$ Million) Table 54. Global Romosozumab Sales Market Share in Value by Application (2021-2026) Table 55. Global Romosozumab Price by Application (2021-2026) & (USD/unit) Table 56. Global Romosozumab Sales by Application (2027-2032) & (k units) Table 57. Global Romosozumab Sales Market Share in Volume by Application (2027-2032) Table 58. Global Romosozumab Sales by Application (2027-2032) & (US$ Million) Table 59. Global Romosozumab Sales Market Share in Value by Application (2027-2032) Table 60. Global Romosozumab Price by Application (2027-2032) & (USD/unit) Table 61. North America Romosozumab Sales by Application (2021-2026) & (k units) Table 62. North America Romosozumab Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Romosozumab Sales by Application (2021-2026) & (k units) Table 64. Europe Romosozumab Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Romosozumab Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Romosozumab Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Romosozumab Sales by Application (2021-2026) & (k units) Table 68. Latin America Romosozumab Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Romosozumab Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Romosozumab Sales by Application (2021-2026) & (US$ Million) Table 71. Thermo Fisher Scientific Company Information Table 72. Thermo Fisher Scientific Business Overview Table 73. Thermo Fisher Scientific Romosozumab Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Thermo Fisher Scientific Romosozumab Product Portfolio Table 75. Thermo Fisher Scientific Recent Development Table 76. Bristol-Myers Squibb Company Information Table 77. Bristol-Myers Squibb Business Overview Table 78. Bristol-Myers Squibb Romosozumab Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Bristol-Myers Squibb Romosozumab Product Portfolio Table 80. Bristol-Myers Squibb Recent Development Table 81. Celgene Company Information Table 82. Celgene Business Overview Table 83. Celgene Romosozumab Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Celgene Romosozumab Product Portfolio Table 85. Celgene Recent Development Table 86. North America Romosozumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 87. North America Romosozumab Sales by Country (2021-2026) & (k units) Table 88. North America Romosozumab Sales Market Share by Country (2021-2026) Table 89. North America Romosozumab Sales Forecast by Country (2027-2032) & (k units) Table 90. North America Romosozumab Sales Market Share Forecast by Country (2027-2032) Table 91. North America Romosozumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Romosozumab Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Romosozumab Market Share by Country (2021-2026) Table 94. North America Romosozumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Romosozumab Market Share Forecast by Country (2027-2032) Table 96. Europe Romosozumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. Europe Romosozumab Sales by Country (2021-2026) & (k units) Table 98. Europe Romosozumab Sales Market Share by Country (2021-2026) Table 99. Europe Romosozumab Sales Forecast by Country (2027-2032) & (k units) Table 100. Europe Romosozumab Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Romosozumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Romosozumab Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Romosozumab Market Share by Country (2021-2026) Table 104. Europe Romosozumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Romosozumab Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Romosozumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Romosozumab Sales by Country (2021-2026) & (k units) Table 108. Asia-Pacific Romosozumab Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Romosozumab Sales Forecast by Country (2027-2032) & (k units) Table 110. Asia-Pacific Romosozumab Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Romosozumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Romosozumab Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Romosozumab Market Share by Country (2021-2026) Table 114. Asia-Pacific Romosozumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Romosozumab Market Share Forecast by Country (2027-2032) Table 116. Latin America Romosozumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Latin America Romosozumab Sales by Country (2021-2026) & (k units) Table 118. Latin America Romosozumab Sales Market Share by Country (2021-2026) Table 119. Latin America Romosozumab Sales Forecast by Country (2027-2032) & (k units) Table 120. Latin America Romosozumab Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Romosozumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Romosozumab Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Romosozumab Market Share by Country (2021-2026) Table 124. Latin America Romosozumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Romosozumab Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Romosozumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Romosozumab Sales by Country (2021-2026) & (k units) Table 128. Middle East and Africa Romosozumab Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Romosozumab Sales Forecast by Country (2027-2032) & (k units) Table 130. Middle East and Africa Romosozumab Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Romosozumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Romosozumab Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Romosozumab Market Share by Country (2021-2026) Table 134. Middle East and Africa Romosozumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Romosozumab Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Romosozumab Distributors List Table 139. Romosozumab Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Romosozumab Image Figure 2. Global Romosozumab Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Romosozumab Market Size (2021-2032) & (US$ Million) Figure 4. Global Romosozumab Sales (2021-2032) & (k units) Figure 5. 25 mg/vial Image Figure 6. Global 25 mg/vial Sales YoY Growth (2021-2032) & (k units) Figure 7. 75 mg/vial Image Figure 8. Global 75 mg/vial Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Romosozumab Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Romosozumab Market Share by Type 2025 VS 2032 Figure 11. North America Romosozumab Sales Market Share in Volume by Type in 2025 Figure 12. North America Romosozumab Sales Market Share in Value by Type in 2025 Figure 13. Europe Romosozumab Sales Market Share in Volume by Type in 2025 Figure 14. Europe Romosozumab Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Romosozumab Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Romosozumab Sales Market Share in Value by Type in 2025 Figure 17. Latin America Romosozumab Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Romosozumab Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Romosozumab Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Romosozumab Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Romosozumab Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Beta-thalassemia Image Figure 24. Global Beta-thalassemia Sales YoY Growth (2021-2032) & (k units) Figure 25. MDS-RS Image Figure 26. Global MDS-RS Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Romosozumab Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Romosozumab Market Share by Application 2025 VS 2032 Figure 29. North America Romosozumab Sales Market Share in Volume by Application in 2025 Figure 30. North America Romosozumab Sales Market Share in Value by Application in 2025 Figure 31. Europe Romosozumab Sales Market Share in Volume by Application in 2025 Figure 32. Europe Romosozumab Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Romosozumab Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Romosozumab Sales Market Share in Value by Application in 2025 Figure 35. Latin America Romosozumab Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Romosozumab Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Romosozumab Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Romosozumab Sales Market Share in Value by Application in 2025 Figure 39. North America Romosozumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Romosozumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Romosozumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Romosozumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Romosozumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Romosozumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Romosozumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Romosozumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Romosozumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Romosozumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Romosozumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Romosozumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Romosozumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Romosozumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Romosozumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Romosozumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Romosozumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Romosozumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Romosozumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Romosozumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Romosozumab Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Romosozumab Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 25 mg/vial
  • 75 mg/vial
Applications
  • Beta-thalassemia
  • MDS-RS
Companies covered
  • Thermo Fisher Scientific
  • Bristol-Myers Squibb
  • Celgene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Romosozumab Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Romosozumab Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Romosozumab Market by Type
  6. 1.3.1 25 mg/vial
  7. 1.3.2 75 mg/vial
  8. 1.4 Global Romosozumab Market Size by Type
  9. 1.4.1 Global Romosozumab Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Romosozumab Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Romosozumab Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Romosozumab Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Romosozumab Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Romosozumab Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Romosozumab Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Romosozumab Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Romosozumab Industry Trends
  2. 2.2 Romosozumab Industry Drivers
  3. 2.3 Romosozumab Industry Opportunities and Challenges
  4. 2.4 Romosozumab Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Romosozumab Revenue (2021-2026)
  2. 3.2 Global Top Players by Romosozumab Sales (2021-2026)
  3. 3.3 Global Top Players by Romosozumab Price (2021-2026)
  4. 3.4 Global Romosozumab Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Romosozumab Major Company Production Sites & Headquarters
  6. 3.6 Global Romosozumab Company, Product Type & Application
  7. 3.7 Global Romosozumab Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Romosozumab Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Romosozumab Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Romosozumab Tier 1, Tier 2, and Tier 3
4 Romosozumab Regional Status and Outlook
  1. 4.1 Global Romosozumab Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Romosozumab Historic Market Size by Region
  3. 4.2.1 Global Romosozumab Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Romosozumab Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Romosozumab Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Romosozumab Forecasted Market Size by Region
  7. 4.3.1 Global Romosozumab Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Romosozumab Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Romosozumab Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Romosozumab by Application
  1. 5.1 Romosozumab Market by Application
  2. 5.1.1 Beta-thalassemia
  3. 5.1.2 MDS-RS
  4. 5.2 Global Romosozumab Market Size by Application
  5. 5.2.1 Global Romosozumab Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Romosozumab Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Romosozumab Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Romosozumab Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Romosozumab Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Romosozumab Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Romosozumab Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Romosozumab Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Romosozumab Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Romosozumab Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Bristol-Myers Squibb
  8. 6.2.1 Bristol-Myers Squibb Company Information
  9. 6.2.2 Bristol-Myers Squibb Business Overview
  10. 6.2.3 Bristol-Myers Squibb Romosozumab Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bristol-Myers Squibb Romosozumab Product Portfolio
  12. 6.2.5 Bristol-Myers Squibb Recent Developments
  13. 6.3 Celgene
  14. 6.3.1 Celgene Company Information
  15. 6.3.2 Celgene Business Overview
  16. 6.3.3 Celgene Romosozumab Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Celgene Romosozumab Product Portfolio
  18. 6.3.5 Celgene Recent Developments
7 North America by Country
  1. 7.1 North America Romosozumab Sales by Country
  2. 7.1.1 North America Romosozumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Romosozumab Sales by Country (2021-2026)
  4. 7.1.3 North America Romosozumab Sales Forecast by Country (2027-2032)
  5. 7.2 North America Romosozumab Market Size by Country
  6. 7.2.1 North America Romosozumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Romosozumab Market Size by Country (2021-2026)
  8. 7.2.3 North America Romosozumab Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Romosozumab Sales by Country
  2. 8.1.1 Europe Romosozumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Romosozumab Sales by Country (2021-2026)
  4. 8.1.3 Europe Romosozumab Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Romosozumab Market Size by Country
  6. 8.2.1 Europe Romosozumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Romosozumab Market Size by Country (2021-2026)
  8. 8.2.3 Europe Romosozumab Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Romosozumab Sales by Country
  2. 9.1.1 Asia-Pacific Romosozumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Romosozumab Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Romosozumab Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Romosozumab Market Size by Country
  6. 9.2.1 Asia-Pacific Romosozumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Romosozumab Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Romosozumab Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Romosozumab Sales by Country
  2. 10.1.1 South America Romosozumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Romosozumab Sales by Country (2021-2026)
  4. 10.1.3 South America Romosozumab Sales Forecast by Country (2027-2032)
  5. 10.2 South America Romosozumab Market Size by Country
  6. 10.2.1 South America Romosozumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Romosozumab Market Size by Country (2021-2026)
  8. 10.2.3 South America Romosozumab Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Romosozumab Sales by Country
  2. 11.1.1 Middle East and Africa Romosozumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Romosozumab Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Romosozumab Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Romosozumab Market Size by Country
  6. 11.2.1 Middle East and Africa Romosozumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Romosozumab Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Romosozumab Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Romosozumab Value Chain Analysis
  2. 12.1.1 Romosozumab Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Romosozumab Production Mode & Process
  7. 12.2 Romosozumab Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Romosozumab Distributors
  10. 12.2.3 Romosozumab Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst